急性敌草快中毒诊断与治疗专家共识

2020-10-30 中华急诊医学杂志.2020.29(10):1282-1289.

急性敌草快中毒在流行病学、毒代动力学、临床诊治等相关文献较少,国内外尚无诊疗指南和共识。鉴于目前对敌草快中毒的认识尚不全面,本共识由专家组在查阅现有文献的基础上,依据文献数据和专家的临床经验共同总结、

中文标题:

急性敌草快中毒诊断与治疗专家共识

发布机构:

发布日期:

2020-10-30

简要介绍:

急性敌草快中毒在流行病学、毒代动力学、临床诊治等相关文献较少,国内外尚无诊疗指南和共识。鉴于目前对敌草快中毒的认识尚不全面,本共识由专家组在查阅现有文献的基础上,依据文献数据和专家的临床经验共同总结、起草,以期制定一个现阶段适合我国临床需求的急性敌草快中毒诊疗的指导性文件。

下载附件:

(因为版权问题,不支持下载)

评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1193447, encodeId=4ed8119344eeb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211018/cf8f772ab38148e8ac2cb234229f8f71/4fea1ac6fb8a4a6ca1be5e0817ee1b81.jpg, createdBy=65685639002, createdName=我不是针对谁, createdTime=Tue Feb 15 01:10:28 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181633, encodeId=8301118163373, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI2o2q22rWZ7Oy0a9XPFdHnVQ7yx7n94ezAVHucnGpyS9yicUAfX6NzVicPdtJOXrEbicQA7Lyo4x9kA/132, createdBy=72095240478, createdName=jipenghui456, createdTime=Thu Jan 06 23:27:38 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179240, encodeId=499711e9240d8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/95a6dce31e174b2da437bbf0d7090c4c/18a48c44e42e4055ad2157fc5a9a4353.jpg, createdBy=b8865528278, createdName=祥叔, createdTime=Fri Dec 31 12:36:12 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061378, encodeId=effe10613e80d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/59254aca744b425289567656ffe19932/8fe6af70e2594158a8287c817a1c41d6.jpg, createdBy=92785573268, createdName=重症的潘潘, createdTime=Mon Oct 18 07:43:48 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050132, encodeId=53b01050132b0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78235589459, createdName=ms3000000183190163, createdTime=Tue Sep 14 04:37:57 CST 2021, time=2021-09-14, status=1, ipAttribution=)]
    2022-02-15 我不是针对谁

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1193447, encodeId=4ed8119344eeb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211018/cf8f772ab38148e8ac2cb234229f8f71/4fea1ac6fb8a4a6ca1be5e0817ee1b81.jpg, createdBy=65685639002, createdName=我不是针对谁, createdTime=Tue Feb 15 01:10:28 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181633, encodeId=8301118163373, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI2o2q22rWZ7Oy0a9XPFdHnVQ7yx7n94ezAVHucnGpyS9yicUAfX6NzVicPdtJOXrEbicQA7Lyo4x9kA/132, createdBy=72095240478, createdName=jipenghui456, createdTime=Thu Jan 06 23:27:38 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179240, encodeId=499711e9240d8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/95a6dce31e174b2da437bbf0d7090c4c/18a48c44e42e4055ad2157fc5a9a4353.jpg, createdBy=b8865528278, createdName=祥叔, createdTime=Fri Dec 31 12:36:12 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061378, encodeId=effe10613e80d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/59254aca744b425289567656ffe19932/8fe6af70e2594158a8287c817a1c41d6.jpg, createdBy=92785573268, createdName=重症的潘潘, createdTime=Mon Oct 18 07:43:48 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050132, encodeId=53b01050132b0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78235589459, createdName=ms3000000183190163, createdTime=Tue Sep 14 04:37:57 CST 2021, time=2021-09-14, status=1, ipAttribution=)]
    2022-01-06 jipenghui456

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1193447, encodeId=4ed8119344eeb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211018/cf8f772ab38148e8ac2cb234229f8f71/4fea1ac6fb8a4a6ca1be5e0817ee1b81.jpg, createdBy=65685639002, createdName=我不是针对谁, createdTime=Tue Feb 15 01:10:28 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181633, encodeId=8301118163373, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI2o2q22rWZ7Oy0a9XPFdHnVQ7yx7n94ezAVHucnGpyS9yicUAfX6NzVicPdtJOXrEbicQA7Lyo4x9kA/132, createdBy=72095240478, createdName=jipenghui456, createdTime=Thu Jan 06 23:27:38 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179240, encodeId=499711e9240d8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/95a6dce31e174b2da437bbf0d7090c4c/18a48c44e42e4055ad2157fc5a9a4353.jpg, createdBy=b8865528278, createdName=祥叔, createdTime=Fri Dec 31 12:36:12 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061378, encodeId=effe10613e80d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/59254aca744b425289567656ffe19932/8fe6af70e2594158a8287c817a1c41d6.jpg, createdBy=92785573268, createdName=重症的潘潘, createdTime=Mon Oct 18 07:43:48 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050132, encodeId=53b01050132b0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78235589459, createdName=ms3000000183190163, createdTime=Tue Sep 14 04:37:57 CST 2021, time=2021-09-14, status=1, ipAttribution=)]
    2021-12-31 祥叔

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1193447, encodeId=4ed8119344eeb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211018/cf8f772ab38148e8ac2cb234229f8f71/4fea1ac6fb8a4a6ca1be5e0817ee1b81.jpg, createdBy=65685639002, createdName=我不是针对谁, createdTime=Tue Feb 15 01:10:28 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181633, encodeId=8301118163373, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI2o2q22rWZ7Oy0a9XPFdHnVQ7yx7n94ezAVHucnGpyS9yicUAfX6NzVicPdtJOXrEbicQA7Lyo4x9kA/132, createdBy=72095240478, createdName=jipenghui456, createdTime=Thu Jan 06 23:27:38 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179240, encodeId=499711e9240d8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/95a6dce31e174b2da437bbf0d7090c4c/18a48c44e42e4055ad2157fc5a9a4353.jpg, createdBy=b8865528278, createdName=祥叔, createdTime=Fri Dec 31 12:36:12 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061378, encodeId=effe10613e80d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/59254aca744b425289567656ffe19932/8fe6af70e2594158a8287c817a1c41d6.jpg, createdBy=92785573268, createdName=重症的潘潘, createdTime=Mon Oct 18 07:43:48 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050132, encodeId=53b01050132b0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78235589459, createdName=ms3000000183190163, createdTime=Tue Sep 14 04:37:57 CST 2021, time=2021-09-14, status=1, ipAttribution=)]
    2021-10-18 重症的潘潘

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1193447, encodeId=4ed8119344eeb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211018/cf8f772ab38148e8ac2cb234229f8f71/4fea1ac6fb8a4a6ca1be5e0817ee1b81.jpg, createdBy=65685639002, createdName=我不是针对谁, createdTime=Tue Feb 15 01:10:28 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181633, encodeId=8301118163373, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI2o2q22rWZ7Oy0a9XPFdHnVQ7yx7n94ezAVHucnGpyS9yicUAfX6NzVicPdtJOXrEbicQA7Lyo4x9kA/132, createdBy=72095240478, createdName=jipenghui456, createdTime=Thu Jan 06 23:27:38 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179240, encodeId=499711e9240d8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/95a6dce31e174b2da437bbf0d7090c4c/18a48c44e42e4055ad2157fc5a9a4353.jpg, createdBy=b8865528278, createdName=祥叔, createdTime=Fri Dec 31 12:36:12 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061378, encodeId=effe10613e80d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/59254aca744b425289567656ffe19932/8fe6af70e2594158a8287c817a1c41d6.jpg, createdBy=92785573268, createdName=重症的潘潘, createdTime=Mon Oct 18 07:43:48 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050132, encodeId=53b01050132b0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78235589459, createdName=ms3000000183190163, createdTime=Tue Sep 14 04:37:57 CST 2021, time=2021-09-14, status=1, ipAttribution=)]
    2021-09-14 ms3000000183190163

    学习

    0